NCT04936308 2026-04-13
SOLSTICE
Janssen Research & Development, LLC
Phase 3 Active not recruiting
Clinical Trials
5 trialsNCT03649971 2025-02-03
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
Phase 1 Completed
NCT03796858 2025-02-03
COSMOS
Janssen Pharmaceutica N.V., Belgium
Phase 3 Completed
NCT04948398 2025-02-03
Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
No longer available
NCT03162796 2021-02-03
Discover-1
Janssen Research & Development, LLC
Phase 3 Completed